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See related research by Thille et al., http://ccforum.biomedcentral.com/articles/10.1186/s13054-016-1228-2We read with great interest the article by Thille et al. [1]
and commend the authors on their work. It is accepted
that noninvasive ventilation (NIV) used prophylactically
reduces post-extubation respiratory failure, but its im-
pact on reintubation remains contentious [2]. Therefore,
the current study, which reports reduced rates of reintu-
bation from 28 % to 15 % in high-risk populations with
NIV use, is welcomed.
The study has several limiting factors. It is a prospect-
ive before–after study across a long time period, and the
authors acknowledge this potential source of bias. There
is a large gap between patient cohorts, with data from
the original cohort collected between 2005 and 2006 and
data from the “after” group collected between 2010 and
2012. No explanation is provided as to why this second
period—4 years later—was chosen, which raises con-
cerns regarding selection bias. Additionally, data were
collected from a single centre with extensive experience
of NIV use, an important factor in the success of NIV
use post-extubation [3].
In mitigation, no difference between baseline reintuba-
tion rates of low-risk patients was seen between the two
groups, and the second patient cohort contained fewer
surgical patients—a group known to benefit from post-
extubation NIV use [4].
We applaud the definition of extubation failure as
reintubation within 7 days rather than 48–72 h, as we
feel this provides a pragmatic view. It is likely to result
in greater numbers of extubation failures and makes the
findings more impressive. We also feel that an average* Correspondence: alastair.glossop@sth.nhs.uk
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reproducible period for prophylactic use in critical care
patients, in whom treatment compliance may be an
issue.
We feel that this is an important study and welcome
its contribution to the evidence pool. It does, however,
raise the important question of what constitutes “high
risk” of extubation failure. The authors state that NIV is
“pointless” as a prophylactic measure in low-risk popula-
tions, but define over 60 % of patients included as high
risk; as demands on frontline services increase this figure
is surely set to rise. The emergence of high-flow nasal
cannula (HFNC) therapy in patients defined as low risk
of extubation failure [5] brings an even sharper focus on
the need for risk stratification in all ICU patients, and
further work is warranted to help guide post-extubation
management.
Abbreviations
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